CYP1A2 rs2245480: Understanding Your Caffeine Metabolism
The rs2245480 variant is a genetic marker located within the CYP1A2 gene, which plays a central role in how your body processes caffeine. This variant is studied for its potential to influence the rate at which individuals metabolize caffeine, categorizing them as either faster or slower processors.
What each genotype means
Rapid caffeine metabolizer
Individuals with this genotype are typically classified as rapid caffeine metabolizers, meaning the CYP1A2 enzyme processes caffeine more efficiently. You may find that you can consume caffeine closer to bedtime with less impact on your sleep compared to others. Please discuss your caffeine intake and any concerns regarding stimulant sensitivity with your healthcare provider.
This genotype is common in many populations, though frequencies vary significantly by ancestry.
Intermediate caffeine metabolizer
This genotype is associated with intermediate rates of caffeine metabolism. Your body processes caffeine at a moderate speed, which may result in a balance between the stimulating effects and the duration of caffeine in your system. If you experience jitteriness or sleep disturbances, consider adjusting your daily caffeine intake and consult with a clinician or pharmacist regarding your sensitivity.
This heterozygous genotype is frequently observed across diverse global populations.
Slow caffeine metabolizer
Carriers of this genotype are often categorized as slow caffeine metabolizers, as the CYP1A2 enzyme may process caffeine less efficiently. Caffeine may remain in your system for a longer duration, potentially increasing the likelihood of side effects like anxiety or sleep disruption if consumed in high amounts. You may wish to monitor your caffeine intake and discuss any persistent symptoms with your healthcare provider.
This genotype is common, though its prevalence varies widely depending on ethnic and geographic background.
What is the rs2245480 Variant?
The rs2245480 variant is a single nucleotide polymorphism (SNP) situated within the CYP1A2 gene, which is located on chromosome 15q24.1. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is part of a broader set of genetic markers within the CYP1A2 region that researchers investigate to understand inter-individual differences in drug and compound metabolism. Because this gene is highly active in the liver, variations here can alter the efficiency of the enzymes produced. While rs2245480 is often discussed in the context of nutrigenomics, it is important to recognize that it is one of several markers in the CYP1A2 gene that collectively contribute to the complex, polygenic nature of how our bodies handle substances like caffeine.
The Role of the CYP1A2 Gene
The CYP1A2 gene provides instructions for making the cytochrome P450 1A2 enzyme. This enzyme is a member of the cytochrome P450 family, which is responsible for the metabolism of a wide variety of substances, including medications, toxins, and dietary components. Specifically, CYP1A2 is the primary enzyme responsible for the breakdown of caffeine in the liver. By converting caffeine into its metabolites, the enzyme helps clear the stimulant from your system. The activity of this enzyme is not static; it can be influenced by environmental factors such as smoking, which induces or increases enzyme activity, as well as by genetic variations. Because caffeine metabolism is a heritable trait, variations in the CYP1A2 gene sequence are key factors in why some people feel the effects of a cup of coffee for several hours, while others feel them for a much shorter duration.
Research and Evidence Strength
Research into CYP1A2 variants, including rs2245480, is categorized as having moderate evidence strength regarding its impact on caffeine metabolism. Scientific studies often look at how these genotypes correlate with caffeine consumption habits, exercise performance, and potential health outcomes like blood pressure or kidney function. While some studies suggest that specific genotypes are associated with faster or slower clearance rates, the results can be nuanced and sometimes conflicting due to the influence of other genes, diet, and lifestyle factors. It is essential to note that while associations have been observed in various populations, these findings are generally used for educational purposes rather than clinical diagnosis. The field of nutrigenomics is still evolving, and researchers continue to refine how these genetic markers interact with environmental variables to influence human physiology.
Population Frequency and Interpretation
The rs2245480 variant is considered common across many global populations. Genetic frequency can vary significantly depending on ancestral background, meaning that the distribution of specific genotypes is not uniform worldwide. Because this variant is common, it is a frequent subject of study in large-scale genomic research. When interpreting information about this variant, it is important to remember that genetics is only one piece of the puzzle. Factors such as age, liver health, concurrent medication use, and smoking status play significant roles in how caffeine is metabolized. If you are interested in how your genetic profile might influence your response to caffeine or medications, it is best to consult with a healthcare professional or a registered dietitian who can provide personalized guidance based on your full health history.
How common is this variant?
The rs2245480 variant is common across diverse ancestral populations, with genotype frequencies varying by region.
Frequently asked questions
Does my CYP1A2 genotype mean I should stop drinking coffee?
No, your genotype does not dictate your dietary choices. It simply provides information on how your body might process caffeine, and you should discuss any concerns about your caffeine intake with a healthcare provider.
Can I use this test to diagnose a health condition?
No. Genetic variants like rs2245480 are used for educational and research purposes. They are not diagnostic tools for any medical condition.
How does smoking affect my CYP1A2 gene?
Smoking is known to induce the activity of the CYP1A2 enzyme, which can increase the rate at which caffeine is metabolized regardless of your specific genotype. This environmental factor often overrides the subtle effects of genetic variants.
Should I change my medication dosage based on this result?
Absolutely not. Never change the dosage of any medication based on genetic test results without consulting your doctor or pharmacist, as they must consider your entire clinical profile.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2245480?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1A2
Located in intron 1 of CYP1A2, this variant modulates inducible enzyme activity, altering systemic caffeine clearance and individual susceptibility to caffeine-related blood pressure increases.
Intronic regulatory polymorphism associated with CYP1A2 inducibility and differences in dietary caffeine metabolism rates.
Non-coding modifier variant in linkage disequilibrium with CYP1A2*1F altering the inducibility of caffeine degradation following coffee consumption.
Functional CYP1A2 variant modulating enzyme inducibility and influencing metabolic breakdown of dietary compounds such as caffeine.
Influences caffeine metabolism velocity and hepatic clearance.
Intergenic regulatory variant linked to the CYP1A1-CYP1A2 locus associated with habitual coffee consumption and caffeine clearance velocity.